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Abstract
The number of new infections per day is a key quantity for effective epidemic management. It can
be estimated relatively directly by testing of random population samples. Without such direct epi-
demiological measurement, other approaches are required to infer whether the number of new cases
is likely to be increasing or decreasing: for example, estimating the pathogen effective reproduction
number, R, using data gathered from the clinical response to the disease. For Covid-19 (SARS-CoV-
2) such R estimation is heavily dependent on modelling assumptions, because the available clinical
case data are opportunistic observational data subject to severe temporal confounding. Given this
difficulty it is useful to retrospectively reconstruct the time course of infections from the least com-
promised available data, using minimal prior assumptions. A Bayesian inverse problem approach
applied to UK data on first wave Covid-19 deaths and the disease duration distribution suggests that
fatal infections were in decline before full UK lockdown (24 March 2020), and that fatal infections
in Sweden started to decline only a day or two later. An analysis of UK data using the model of
Flaxman et al. (2020) gives the same result under relaxation of its prior assumptions on R, suggest-
ing an enhanced role for non pharmaceutical interventions (NPIs) short of full lock down in the UK
context. Similar patterns appear to have occurred in the subsequent two lockdowns. Estimates from
the main UK Covid statistical surveillance surveys, available since original publication, support these
results.
1 Introduction
Clinical data on the number of cases of Covid-19 (SARS-CoV-2) are subject to severe temporal con-
founding, as the rate of testing and criteria for testing have been changing rapidly on the same time scale
as the infections, particularly in the early weeks and months of the epidemic. Because these are samples
of convenience where the ascertainment fraction is changing and unknown, the data can clearly not be
used to infer the actual number of infections. Neither, under normal circumstances, would statisticians
recommend attempting to estimate the effective reproduction number of the pathogen from such data,
since given the data problems the estimates must necessarily be driven strongly by the modelling as-
sumptions (see e.g. Levine et al., 2001, §1.6 for general discussion of the problems with inference from
non-random samples). Indeed generically it is often very difficult to infer epidemiological parameters
from clinical data, without the results being informed as much by the prior beliefs encoded in the model
as by the data (e.g. Wood et al., 2020). Much less problematic are estimates based on randomized surveil-
lance testing, as now conducted in the UK by the office for national statistics (see Supporting Information
for discussion of inferring incidence from testing data).
However some clinical data directly measure the quantity of epidemiological interest. This is the
case for deaths with Covid-19 and for fatal disease duration. While not perfect, these data are less
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compromised than the data on cases. Deaths are reliably recorded and clinical grounds for suspecting
Covid-19 are relatively clear for fatal cases, although accurately attributing death to a single cause is
clearly not always possible. Good records are also often kept for such cases, with the result that there
are several published studies on fatal disease duration (Verity et al., 2020; Linton et al., 2020; Wu et al.,
2020, see section 2). Although only possible with a delay of some weeks, it is of interest to establish what
these relatively high quality data imply about the time course of infections, without strong modelling
assumptions.
Two types of daily death data are available. Daily reported deaths (e.g. Worldometer, 2020) typically
show marked weekly fluctuations as a result of weekly patterns in reporting delays, and may exclude
deaths in some locations (such as nursing homes). Registered death data, such as the ONS data in the UK
(Office for National Statistics, 2020), contain deaths in all locations and record exact date of death. NHS
(2020) publishes equivalent data for hospital deaths in England. The weekly cycle is less pronounced in
these data, but their release is necessarily delayed relative to the daily reported deaths, although recent
work partially overcomes this delay problem, by modelling the delays to enable ‘now-casting’ of deaths
by actual death date: see Stoner et al. (2020). The right column of Figure 2 shows ONS, NHS and
Swedish daily deaths by date of death (without now-casting).
The purpose of this paper is to show how a relatively straightforward statistical approach can be used
to infer the fatal infection trajectory in the UK in a data driven way that makes the minimum of strong
modelling assumptions. The approach is also applied to data from Sweden, the western European country
offering the greatest policy contrast to the UK. Sweden never implemented full lockdown, sticking to less
restrictive NPIs (broadly aimed at ‘optimal mitigation’ rather than ‘suppression’ in the terms used by
Walker et al., 2020, who projected around 40 thousand deaths for this policy). Meaningful quantification
of the aggregate strength of restrictions that are intrinsically multivariate is difficult, but in terms of their
aggregate economic impact, Swedish GDP dropped by about 2.9% in 2020 compared to about 9.9% for
the UK. Particular questions of interest are when the decline in fatal infections started in the UK and
Sweden, whether UK infections were in substantial decline before full lockdown, whether the pathogen
reproduction number was below 1 before lockdown, and how the timing of fatal incidence decline relates
to the timing of the easing of lockdown.
Answers to these questions may contribute to judging the proportionality of lockdown measures
in the UK context, where there is strong statistical evidence for very large preventable life loss being
associated with economic deprivation, and of economic deprivation being increased by economic shocks.
This evidence is reviewed in detail in Marmot et al. (2020). For example the deprivation related life loss
that the current UK population was due to suffer before the Covid crisis was 140-240 million life years
(or 2-3.5 years per capita, see Marmot et al., 2020, figure 2.3, for example). The range depends on
whether the life expectancy of the lower decile or the lower half of the deprivation distribution is used
as the reference for achievable life-expectancy. In examining the effects of the 2008 financial crisis and
its aftermath, Marmot documents sharp reductions in life expectancy growth in the UK, which would
imply a life loss burden in the 10s of millions of years. However attribution of such reduction-relative-
to-trend is obviously very difficult. Less problematic is the 9 million life year loss implied by the increase
in life expectancy gap between the more and less deprived halves of the UK population since 2008 (7
weeks per capita, see Marmot et al., 2020, figure 2.5, for example): given the evidence presented in the
review, this is more difficult to attribute to causes unrelated to the 2008 economic shock. The Bank
of England estimates the shock to the UK economy caused by the response to Covid-19 to have been
the largest for over 300 years, so there is a clear danger of substantial life loss being caused, given the
historical data for the UK. For example, a feature of the 2008 crisis already repeated in 2020, is the
reliance on a large programme of quantitative easing. Quantitative easing is credibly argued to directly
increase economic inequality via mechanisms related to asset price inflation (e.g. Fontan et al., 2016;
Domanski et al., 2016). There is some literature attributing some short-term life saving to recessions
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(see e.g. Anon, 2020), but the effects are modest relative to the long term effects reviewed by Marmot.
For comparison with the above figures, the life loss that might have occurred from a minimally mitigated
Covid-19 epidemic appears to be in the region of 3 million life years (2.5 weeks per capita). This is
based on Office for National Statistics (2019) lifetables, ONS Covid-19 fatality by age data, a mid range
infection fatality rate estimate of 0.006, a somewhat high herd immunity threshold of 0.7 and a 1 year
lower bound life expectancy adjustment for co-morbidities based on Hanlon et al. (2020). It is broadly
in line with the UK government estimates (Anon, 2020). Given that 9 million life years, associated
with the substantially smaller economic shock of 2008, is not negligible relative to 3 million life years
potentially losable to Covid-19, there is obviously a delicate balance to be struck in the UK context,
and evidence based on assumption light inference should probably play a role in shaping that balance.
Another indicator of the difficulty of achieving the right balance is that the usual UK threshold for
approving a pharmaceutical intervention is £30,000 per life year saved. On the basis of economic costs
detailed in OBR (2020), and the preceding life loss figures, the non-pharmaceutical interventions used
in the UK appear to have a cost per life year saved that is an order of magnitude higher than this (excess
government borrowing is projected to peak at £660 Billion in the OBR central scenario, for example).
This discrepancy in willingness to pay may lead to a problem of opportunity cost, as the same money
can not be spent on preventing other life loss, such as that associated with economic hardship.
The remainder of the paper is structured as follows. Section 2 discusses the available information
on the distribution of fatal disease durations, and how to combine it while adequately characterizing the
associated uncertainty. Section 3 introduces a simple generalized additive model for direct modelling of
the daily deaths trajectories, and shows how it can be extended to infer the trajectory of fatal infections,
either directly or by inferring the trajectory of the pathogen effective reproduction number, R, in a simple
epidemic model. Since the extensions are not standard models, and are relatively expensive to compute
with using standard Bayesian software, section 4 outlines methods allowing computationally efficient
inference with the models. Section 5 presents the main results on infection trajectories, and also the
estimation of R. Section 6 discusses possible problems with the approach, in particular examining
whether smoothness assumptions could be leading to substantial bias in inferred timings. Replication
code and data are provided in the Supporting Information.
2 Fatal disease duration
Data on the incubation period from infection to onset of symptoms are analysed in many papers, for
example Lauer et al. (2020) found that the period is 2 to 11 days for 95% of people, with a median of 5.2
days. A meta-analysis by McAloon et al. (2020) suggests a log-normal distribution with log scale mean
and standard deviation of 1.63 and 0.50. The uncertainty in this distribution is negligible in comparison
to the uncertainty in the distribution of times from onset of symptoms to death discussed next.
Several studies estimate the distribution of time from onset of symptoms to death, while properly
controlling for the right truncation in the fatal duration data. Verity et al. (2020) found that the distribu-
tion of time from onset of symptoms to death for fatal cases can be modelled by a gamma density with
mean 17.8 and standard deviation 8.44, based on 24 patients from Wuhan. Wu et al. (2020) suggested
a gamma density model with mean 20 and standard deviation 10 based on 41 patients from Wuhan.
Linton et al. (2020) found that a log normal model offers a slightly better fit, and estimated a mean of
20.2 days and standard deviation of 11.6 days from 34 patients internationally. These distributions are
shown in the left panel of Figure 1. A simple meta-analysis approach was used to combine the models.
Samples of the correct size were simulated from each model and a log normal model was estimated by
maximum likelihood for the combined resulting sample (n = 99). A further log normal was also fitted
(minimizing Kullback Leibler divergence) to the infection to death distribution implied by the fitted onset
to death distribution and McAloon et al. (2020) infection to onset distribution (treated as independent).
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Figure 1: Fatal disease duration distributions. Left: onset to death. Dotted Verity et al. (2020) ; dashed
Linton et al. (2020); dash-dot Wu et al. (2020); continuous blue is the log-normal mixture component
for community acquired infection from the English hospital data; blue dashed is from the ISARIC study.
Middle: combined Linton-Verity-Wu onset to death model, thick red is mean model, grey are 100 draws
from the distribution of the combined model, thin blue are as left. Right: as middle, but combined
infection to death model.
This process was repeated to generate replicate distributions. These replicate distributions were treated
as draws from the distribution of infection to death distributions in subsequent analysis. 100 such draws
are shown in fig 1. The log normal was chosen because the careful analysis of Linton et al. (2020) found
it to be a better model than the gamma.
In addition, under strict conditions, I was able to access data on fatal disease durations for deaths
occurring in English hospitals. Access to data with hospital acquired infections filtered out was not pos-
sible, so is was necessary to treat these data as a mixture of hospital and community acquired infections,
as detailed in the Supporting Information. The resulting inferred fatal disease duration distribution for
community acquired infection is plotted in blue in Figure 1 and is consistent with the published studies.
Finally, after the peer reviewed version of this paper was published, I realized that Figure 12 of
Pritchard et al. (2020) gives the cumulative distribution function of the time from hospitalization to death
for 24421 patients in the ISARIC study who had died by the time of the report. Furthermore this is at
a point in time at which recruitment to the study was at a low rate, so that right truncation problems
should be relatively minor. The study also reports the mean and standard deviation of time from onset
to hospitalization. Combining this information as described in the Supporting Information, gives the
densities shown as dashed blue curves in Figure 1. These data offer strong support for the distributions
used in this paper, and in fact suggest that the results may be somewhat more certain than the plotted
uncertainty bands imply.
3 Models
This section first introduces a simple generalized additive model for daily death trajectories, and then
shows how this can be extended to directly infer the trajectory of fatal infections (fatal incidence), without
having to assume any particular dynamic model for the epidemic. The resulting model is no longer a
generalized additive model and is the model that this paper advocates using. Its structure is such that
any method for inference with the model can also be used for inference with the dynamic model of
Flaxman et al. (2020), with appropriate restriction of the incidence trajectory to one representable with
that model. The Flaxman model is presented to allow comparison of the results from the infection
trajectory model with the apparently contradictory results of Flaxman et al., but not to advocate its use.
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Basic deaths series model. Let yi denote the deaths or reported deaths on day i, assumed to follow
a negative binomial distribution with mean µi and variance µi + µ
2
i /θ. Let
log(µi) = f(i) + fw(Di) (1)
where f is a smooth function of time measured in days, and fw is a zero mean cyclic smooth function of
day of the week, Di ∈ {1, 2, . . . , 7}, set up so that f
[k]
w (0) = f
[k]
w (7), where k = 0, 1 or 2 denotes order
of derivative. f(i) represents the underlying log death rate, while fw describes the weekly variation about
that rate. The functions f and fw can be represented using splines with associated smoothing penalties
λ
∫
f ′′(t)2dt and λw
∫
f ′′w(D)
2dD. Hyper-parameters λ and λw control the smoothness of the functions.
The model is a straightforward generalized additive model and (λ, λw) can be estimated as part of model
fitting using a standard empirical Bayes approach as described in Wood (2017). The model provides a
good fit to both the reported deaths and ONS data. As expected fw is greatly attenuated for the ONS data
(it vanishes for Swedish exact death date data).
Infection trajectory model. To estimate the daily infection trajectory the model is extended by ex-
pressing f(i) in terms of the time course of earlier infections. Let fc(i) be the function describing the
variation in the number of eventually fatal infections over time. Let B be the square matrix such that
Bij = π(i−j+1;µ, σ
2) if i ≥ j and 0 otherwise . π denotes an infection-to-death log normal density as
discussed above. For the moment its parameters, µ and σ2, are treated as fixed but this will be relaxed in
section 4.3. Given the continuity of the log normal, the given form for Bij can be viewed as approximat-
ing an integral of π over each day, using the midpoint of the integrand – it is straightforward to approx-
imate the integral more accurately, but given that π is originally estimated from durations discretized to
whole days, any precision gain is illusory. If fc = [fc(0), fc(1), . . .]
T and δ = [δ(1), δ(2), . . .]T then
δ = Bf c, where δ(i) is the expected number of deaths on day i. log fc(i) can be represented using a
spline basis, again with a cubic spline penalty. Working on the log scale ensures that fc is positive, but
is also appealing because it means that a cubic spline penalty on log fc(i) can be interpreted as a first
derivative penalty
∫
r′(t)2dt, acting on the epidemiologists ‘intrinsic growth rate’, r. The final infection
trajectory model is then obtained by simply substituting f(i) = log δ(i) into (1). B is rank deficient, so
inferring fc can be viewed as an inverse problem: without regularization multiple solutions that oscillate
from day-to-day are possible. This ambiguity is removed by the smoothing penalty on log fc.
Relaxed Flaxman model. Since this work was originally undertaken in late April 2020, the work
of Flaxman et al. (2020) has appeared. Flaxman et al. make inferences about the reproduction number,
R, and hence incidence rates, based on death trajectories and the fatal infection duration distribution of
Verity et al. (2020), but do so by modelling the pathogen effective reproduction number Rt within a sim-
ple epidemic ‘renewal model’. Flaxman et al. (2020) represent Rt as a step function with steps allowed
each time the government announced new containment interventions, and a sparsity prior promoting a
small number of steps. In the notation of Flaxman et al. the expected number of infections each day (now












where N is the total initially susceptible population, g1 =
∫ 1.5
0 γ(x)dx and gj =
∫ j+.5
j−.5 γ(x)dx for j > 1.
γ is the p.d.f. of a Gamma distribution with shape parameter 6.5 × 0.622 and scale parameter 0.62−2.
The ct values multiplied by the assumed infection fatality rate give fc. The level of the IFR only matters
for the damping term in the first bracket of the expression for ct — this has almost no effect in practice,
a mid range value of 0.006 was used. The original assumptions about Rt can be relaxed by representing
logRt using a spline basis, with associated penalty as for the other models, while log c1 is also treated
as a free parameter. Hence fc in the infection trajectory model can simply be replaced by the Flaxman
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model with logRt represented as a spline function. The model is otherwise unchanged. This model
is presented only to allow comparison of this paper’s results with those of Flaxman et al. (2020): its
simple single compartment structure clearly does not meet the aim of inferring incidence with minimal
assumptions.
4 Methods
The infection trajectory and Flaxman renewal models are not standard models estimable with standard
software. They can be implemented in Bayesian software, such as JAGS or STAN, but inference typi-
cally takes several hours if this is done. Dealing adequately with the uncertainty in the disease duration
distribution multiplies this cost by 1-2 orders of magnitude. To avoid these problems an empirical Bayes
approach can be employed.
4.1 Basic inferential framework
Direct inference about (1) uses the empirical Bayes approach of Wood et al. (2016) in which the smooth
functions are estimated by penalized likelihood maximisation (e.g. Green and Silverman, 1994), with
the smoothing parameters and θ estimated by Laplace approximate marginal likelihood maximization.
Writing β for the combined vector of basis coefficients for f and fw, the penalized version of the log














where Sλ = λSf + λwSw: Sf and Sw are known constant positive semi-definite matrices. Smoothing
parameters, λ and λw, control the smoothness of f and fw. Let β̂ be the maximizer of the penalized
log likelihood, and H its negative Hessian at β̂. Viewing the penalty as being induced by an improper
Gaussian prior, β ∼ N(0,S−λ ), β̂ is also the MAP estimate of β. Furthermore in the large sample limit
β|y ∼ N(β̂, (H+ Sλ)
−1). (3)
Writing the density in (3) as πg, and the joint density of y and β as π(y,β), the Laplace approximation
to the marginal likelihood for the smoothing parameters λ and θ is π(λ, θ) = π(y,β)/πg(β|y). Nested
Newton iterations are used to find the values of log(λ), θ maximizing π(λ, θ) and the corresponding β̂
(for details see Wood et al., 2016).
Given (3) credible intervals for f are readily computed, but it is also straightforward to make infer-
ences about when the peak in f occurs. Simply simulate replicate coefficient vectors from (3) and find
the day of occurrence of the peak for each corresponding underlying death rate function, f .
4.2 Extension for the infection and Flaxman models
While inference about (1) using the preceding framework requires little more than a call to the gam
function in R package mgcv, its application to the other models, which are not generalized additive
models, requires more work. For the model formulated in terms of fc this requires expressions for the
negative binomial deviance (or log likelihood) and its derivative vector and Hessian matrix w.r.t. the
model coefficients.
First consider the negative binomial deviance for observation i,
















































Writing Xf and Xw for the model matrices for the smooth terms log fc and fw, we have δ = Bf c where
fc = exp(X
fβf ) (here exp(·), division and multiplication are applied element-wise to vectors), and
fw = X



















































When using the relaxed Flaxman model, the preceding derivatives of fc have to be replaced with
derivatives of fc w.r.t. the coefficients of the spline representing logRt. Routine application of the
chain rule to (2) gives corresponding iterations for the derivatives of ct, and hence fc, w.r.t these spline
coefficients and log c1.
Given these expressions and the penalties, β̂ can be obtained by Newton iteration, given smoothing
parameters. To estimate smoothing parameters, the simplest approach is to fix the negative binomial θ
at its estimate from model (1), and use Wood and Fasiolo (2017), alternating generalized Fellner Schall
updates of the smoothing parameters with updates of β̂ given those smoothing parameters. This finds
the smoothing parameters to approximately maximise the model marginal likelihood. The non-linearity
of the renewal equation model means that some effort is required to get non-absurd starting values. I got
these by a few minutes of experimentation with simple step functions for the initial logRt to get death
trajectories of roughly the shape and amplitude of the true trajectories (a close initial fit is not required:
initial deviances 2 orders of magnitude greater than for the final fit were unproblematic).
Given θ and the smoothing parameters, the approximate posterior (3) could be used directly, or as
the basis for the proposal distribution in a simple Metropolis Hastings sampler. A fairly efficient sampler
results from alternating fixed proposals based on (3) with random walk proposals based on zero mean
Gaussian steps with a shrunken version of the posterior covariance matrix. By this method, effective
sample sizes > 5000 for each coefficient took about 40 seconds computing on a low specification laptop.
This was the approach used for the infection trajectory model. The results were indistinguishable from
those produced at the cost of several hours of computing using JAGS (Plummer, 2003; Plummer et al.,
2006) to simulate from the model posterior.
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4.3 Disease duration distribution uncertainty
The methods so far perform inference conditional on fixed values for the parameters µ and σ2 of the
log normal density describing the infection to death duration distribution. In reality there is uncertainty
about these parameters. To incorporate this uncertainty into the infection trajectory model, inference was
run for each of the 100 sample distributions shown in grey in the right hand panel of Figure 1, and the
resulting posterior samples were pooled, to give a sample from the unconditional posterior distribution
of the model.
5 Results
Figure 2 shows the results of applying the model to the Office for National Statistics daily Covid-19
death data for the UK, to the NHS England hospital data and to the daily death data for Sweden from
Folkhälsomyndigheten (2020). The results include the uncertainty about the disease duration distribution
shape. ONS and NHS data are up to 27th June – including later data simply narrows the uncertainty, while
making negligible difference to the overall conclusions. The most notable feature of the results is that
fatal infections are inferred to be in substantial decline before full lockdown (the same result was obtained
by this method in early May 2020, based on the first 50 days of reported daily death data). Sweden
appears most likely to have peaked only one or two days later (barring some systematic difference in
fatal disease durations for Sweden), having introduced NPIs well short of full lockdown. The results also
emphasise the fact that the infection trajectory is not simply a time shifted version of the death trajectory
(assuming it was might lead to unwarranted delay in easing lockdown, for example). The difference in
timing and shape of the inferred profile between the ONS and NHS data reflects the fact that the latter
contain care home data. There is an argument for preferring hospital data for inferring community fatal
infections, in that the care home epidemic is now known to have special features with at least some of
the infection not coming from normal community transmission. See in particular Comas-Herrera et al.
(2020) for a discussion of care home deaths internationally, including the UK. In addition, in the UK,
care home deaths were often attributed to Covid-19 without a test, especially after death certification
guidelines were changed to encourage reporting of suspected, rather than confirmed Covid-19 deaths.
The care home data therefore have some under-reporting of Covid deaths, followed by over-reporting
(the signal of this is visible in ONS data in the change in non-Covid pneumonia deaths being reported,
relative to normal, for example).
Taken together the results for the UK and Sweden raise the questions of firstly whether full lockdown
was necessary to bring infections under control, or whether more limited measures might have been
effective, and secondly whether the several month duration of full lockdown was appropriate. These
emphasise the desirability of statistically well founded direct measurement of epidemic size through
randomized testing. Had such testing being carried out leading up to lockdown it would have been
clearer if the measures preceding lockdown (see Figures 2 and 3) were working, or whether stronger
restrictions were needed. Similarly such testing might have given earlier indication of when lockdown
could be eased. Instead management was reliant on a complex modelling synthesis of expert judgement
and problematic clinical case data. Less statistically problematic reconstructions, like the one presented
here, are clearly only possible weeks after the fact. Note that while it is natural to interpret these fatal
infection trajectories as proportional to the overall infection trajectories, that will only be the case if
the infection fatality rate is constant over time. There is evidence for improvements in hospital care
from late March onwards that suggest that this is might not be the case (see Dennis et al., 2021). The
Supporting Information includes a sensitivity analysis of this issue: it has the potential to right shift the
peak incidence by up to a day and to lead to somewhat less rapid decay of the incidence trajectory.
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Figure 2: In all plots black curves show the posterior median while light grey and dark grey regions
show respectively 95% and 68% confidence regions, including uncertainty in the fatal disease duration
distribution. Day 0 is 13th March 2020, and the vertical red line marks the first day of UK lockdown. Top
left: Inferred daily fatal infection rate, fc, for the UK. The scaled barchart shows the posterior distribution
for day of peak infection with the peak day labelled. NPI start dates are marked by labelled vertical lines.
Top right: Consistency check. In grey are 100 sets of death data simulated forward from the inferred
median fatal infection profile. Symbols are the ONS daily death data for the UK on which inference
is based. The dashed curves are 95% confidence intervals for underlying death rate estimated by direct
fitting of (1). Middle row: As top row, but using the NHS England daily hospital death data. Note that the
inferred infection trajectories are substantially different to time lagged versions of the deaths trajectories.
Bottom row: as the previous rows, but for Sweden.
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Figure 3: Left: Estimates and confidence bands for the effective reproduction number, R, from a simple
SEIR model given the inferred infection profile (incidence), fc. The assumed mean time to infectivity
was 1/γ = 3 days and the mean infectivity duration was 1/δ = 5 days. The labelled vertical bars
show policy change dates in March 2020. Given the rapidity of policy change relative to the epidemic’s
dynamic time scale, and government policy sometimes lagging behaviour, casual over interpretation of
these timings should be avoided. Right: sensitivity analysis. Dashed blue – time to infectivity was varied
from 1 to 5 days. Grey – duration of infectivity was varied from 2 to 10 days. Logs are natural. R
appears to be below 1 before full lockdown, but fell further after it.
5.1 Inferring R
Much public debate has focused on the effective reproduction number, R, and in theory it is possible for
a decline in the rate of infections to be only temporary as a result of R dropping but remaining above
one. Could it be that the declines in fc seen before lockdown were of this short term type, and that
renewed increase would therefore have occurred without full lockdown? The answer appears to be no. R
is all but impossible to measure directly, so inference about it requires assumption of an epidemic model.
However, given an epidemic model it can be directly inferred from the reconstructed infection profile.
For example consider a simple SEIR model: Ṡ = −βSI , Ė = βSI − γE, İ = γE − δI (here δI is the
rate of recovery or progression to serious disease). f̂c is a direct estimate of βSI (to within a constant of
proportionality), so by solving
Ė = f̂c − γE, İ = γE − δI
(from 0 initial conditions) the direct estimate R = fc/(Iδ) is readily computed (any constant of propor-
tionality cancels in R). A different epidemic model could be used here of course: see Diekmann et al.
(1990) for calculation of R in general from a model. Figure 3 shows the results using f̂c for the English
hospital data for plausible values of average time to infectivity of 1/γ = 3 days and mean duration of
infectiousness of 1/δ = 5 days, along with sensitivity analysis for these values. The credible intervals
shown include the uncertainty about the fatal disease duration distribution. R appears to be below 1
before full lockdown.
A useful feature of the R estimates is to emphasise that the analysis in this paper in no way sug-
gests that lockdown did not have an effect on transmission. Even if R was below one before lockdown,
full lockdown can only have reduced it further, and the estimates in Figure 3 are obviously consistent
with this. Note, however that the recovery in R after the post lockdown dip is to be expected, given the
simple fact that R is the number of new infections created per infection, averaged over the population
of infections, not the population of people. Broadly speaking, at lockdown the population of people,
and infections, was split into the locked down population, where infections could create few new infec-
10
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Figure 4: Results from the epidemic model of Flaxman et al. (2020), with the assumptions on R relaxed:
logR is assumed smooth and continuous. Left: the inferred R from fitting the NHS hospital data.
The inferred R trajectory is similar to the one shown in Figure 3, despite the different model structure.
Intervals do not include disease duration distribution uncertainty here. Middle: the corresponding fatal
infection profile. Right: the simple sanity check as in Figure 2.
tions, and the ‘unlocked’ population where the reproductive rate of the pathogen was higher (assuming
lockdown had an effect). An initial average over all infections is then dominated by those infections in
the locked down population, giving a low R (especially once the possibilities for infecting locked down
household members have been exhausted). As the infections in the locked down population die out, the
proportion of all infections that are in the unlocked population must increase – so that an average over
all infections must yield a higher R again.
5.2 The Flaxman model
As noted above in section 3, Flaxman et al. (2020) also analysed death trajectories, using a simple epi-
demic model, but came to conclusions apparently contradicting Figure 3. They concluded that only after
full lockdown did R drop below 1, and that fatal infections continued to increase up until the eve of
full lockdown. Flaxman et al. (2020) used the Verity et al. (2020) fatal disease duration distribution, so
the difference in results does not lie there. To describe the epidemic dynamics Flaxman et al. use the
simple single compartment discrete renewal model (2). Within that model they assume that R is constant
between the imposition of interventions, but can undergo a step change at each intervention: the steps
are free model parameters. This model for R is quite restrictive. In particular it does not allow R to
change after lockdown, despite the fact that at lockdown the population has been stratified in a way that
the renewal model does not represent, so that some compensating flexibility in R is likely to be required
to avoid modelling artefacts. At the same time the model is rather underdetermined preceding lockdown,
because of the frequent intervention changes. This indeterminacy in the model is addressed by using a
sparsity promoting prior on the step changes in R, which favours few larger changes, rather than several
smaller changes (see the supplementary material for Flaxman et al. for a description of this prior). When
using the model to simultaneously model multiple European countries there is a further assumption that
the intervention effects are the same for all countries (despite the different order of their implementation)
and that only the lockdown effect varies between countries. It seems likely to be difficult to pick up
effects of the interventions preceding lockdown from such a model structure.
A relaxed version of the Flaxman model in which logRt is a continuous function is described in
section 3. The results from using this model for inference using the NHS hospital data are shown in
Figure 4. The relaxation of the assumptions on R brings the results (for the UK) into alignment with
those in the rest of this paper, and into broad consistency with developments later in the year, which are
otherwise difficult to square with Flaxman et al. (2020).
11
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Figure 5: Inference for the English hospital deaths data up to mid February 2021, including disease
duration uncertainty. Top: Inferred fatal incidence. Grey symbols are the hospital deaths from which
incidence is inferred. Red vertical lines mark the start of each of the three English lockdowns. Note that
improvements in medical treatment mean that the IFR is very likely not to be constant between the first
and later waves, so comparing their relative sizes is difficult. Bottom: the inferred R using the simple
SEIR approach. NPI impositions short of lockdown are marked by dotted vertical lines, relaxations are
marked by dashed lines.
5.3 Later infection waves
While the initial motivation for this work was to provide reasonably timely analysis for the first wave,
based on the limited data available by May 2020, the methods scale readily to the much longer data
runs available by early 2021. The only change is that it makes sense to use an adaptive smoother (see
e.g. Wood, 2017, §5.3.5) for f(t), in which the degree of smoothness is allowed to vary with time. The
longer data runs make it feasible to estimate the multiple smoothing parameters that this entails. Using
an adaptive smooth guards against artefacts driven by the smoothness that is appropriate on average, for
all the data, not being appropriate at times of rapid change.
The results of this application are shown in Figure 5. Note that likely changes in infection fatality
rate as a result of improved hospital treatment mean that the relative sizes of the fatal infection incidence
curves in the first and subsequent waves can not be interpreted as reflecting the relative sizes of total
incidence (the later incidence curves would need to be scaled up somewhat). Causal over-interpretation
of the R curves should be avoided, not least because there is no reason to expect Covid-19 not to display
the seasonality in transmission common to other respiratory illnesses. However, the results are obviously
inconsistent with full lockdowns having caused R < 1, since cause should not happen after effect.
Further, the drop in R seen after the initial NPIs were introduced, but before full lockdown, does seem
consistent with the levels of R later achieved while measures short of lockdown were in place. The
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interesting feature of R apparently increasing from quite early in the second lockdown, might relate to
the spread of the new variant, but of course also occurs at a time when respiratory infections generally
start to increase. Likewise the further increase until mid December, may well be due to the new variant,
but increased activity in the run up to Christmas is also likely to be a factor – incidence appears to peak
over the Christmas to New Year period. Vaccine rollout seems virtually certain to be a major factor
in pushing down R and fatal incidence from December. The vaccine has been given to those most at
risk first, so the constant IFR assumption required to interpret fatal incidence as proportional to total
incidence obviously no longer holds. This further implies that the inferred R is in some sense only the R
relevant to the ‘at serious risk’ population. Of course, it could be argued that for epidemic management
purposes, the fatal incidence and the corresponding R are of primary interest.
Interestingly the pattern observed at the second lockdown and in the preceding months is consistent
with the results reported by Knock et al. (2020) who analysed regionally stratified death, hospital occu-
pancy and testing data for 2020 up until December, using a highly detailed age structured SEIR with
added health service compartments. The entire trajectory up until December is also consistent with the
results of Wood and Wit (2021), who re-implemented the Knock et al. model, but removed some of its
very strong modelling assumptions around the first lockdown.
6 Model checking
While standard residual checks indicate no problem with the model from the point of view of statistical
fit, there are three issues which could potentially undermine the results, and a further issue relating to
interpretation.
The first relates to the infection to death interval distribution and the fact that the death data contain an
unknown proportion of patients whose infection was hospital acquired. These patients are likely to have
had shorter disease durations, since they were already sufficiently unwell or frail to be in hospital. This
paper has inferred when the fatal infections would have occurred if they were all community generated,
since it is the community infections that are of interest with respect to the effects of lockdown, social
distancing etc. Without knowing even the proportion of deaths from hospital acquired infection it is
anyway not possible to do otherwise.
The presence of hospital infections in the death data will bias inference about the dynamics of com-
munity fatal infections if it substantially changes the shape of the deaths profile, relative to what would
have occurred without hospital infection. Broadly, if the trajectory of hospital acquired infection deaths
peaked earlier than the overall trajectory, then the community infection peak will be estimated to be
earlier than it should be (since the true community infection death peak is then later). Conversely, if
the hospital acquired infection deaths peaked later, then the community infection peak will be estimated
as being later than it should be. The degree of bias will depend on the proportion of hospital acquired
infections and the degree of mismatch in timings. It is difficult to judge which alternative is more likely:
standard epidemiological modelling assumptions would imply that the more community acquired cases
are hospitalised the more hospital infections would occur and that hospital infections will lag community
cases. But against this, hospital acquired fatal disease durations are likely to contain a higher proportion
of shorter durations. In any case the proportion of hospital acquired infections in the death series would
have to be quite high for the issue to substantially modify the conclusions.
The second issue is that age dependency in the duration distribution coupled with shifts in the age
structure of deaths over time could also be problematic. However, as documented in the Supporting
Information, the data for England and Wales show remarkably little variation in the age structure of
Covid-19 fatalities over the course of 2020, while analysis of English hospital data apparently shows
little evidence for age dependence in the disease duration distribution.
The third issue is whether the smoothing penalty on log fc would lead to systematic mis-timing of
13
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Figure 6: Model checking plots in which the smoothness assumptions are relaxed around lockdown by
a time dilation, in order to allow accurate capture of any extremely discontinuous infection profile in
this region. The top row shows the method reconstructing an extreme simulation scenario in which there
was no reduction in transmission rate up until lockdown, and then an instantaneous drop. Left: the
reconstruction (plot meaning as Figure 2) with the true simulated daily infections shown dashed. Right:
forward simulation from the median profile as in Figure 2. The blue symbols are the simulated death data
used for inference. The bottom row is for the NHS England hospital data under the time dilated model.
Even this model deliberately modified to promote a very abrupt change at lockdown suggests that the
infection rate was probably declining before lockdown.
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the estimated peak under the scenario of a very asymmetric peak in the true infection profile around
lockdown. To investigate this, data were simulated from a model in which the underlying infection rate
increased geometrically, doubling every 3 days until lockdown, when the rate dropped immediately to
0.2 of its peak value, shrinking thereafter by 5% per day. Fatal infections were simulated as Poisson
deviates with the given underlying rate. This model is an extreme scenario, in which measures prior to
full lockdown had no effect, and the effect of lockdown was instant, as if the locked down population
(i.e. those not in essential work) had isolated alone, rather than increasing their contact with members
of their household while drastically reducing it with everyone else. However it is the scenario implicit
in much public discussion in the UK, at least at the time that this work was originally conducted. Under
this scenario, the method does indeed tend to incorrectly estimate the infection peak as 2 to 3 days before
lockdown, rather than the day before, as it struggles to accommodate the drop.
The naive approach to this issue is to introduce a parameter at lockdown representing an instan-
taneous drop in infections. However doing so introduces a very strong structural assumption into the
model, undermining the aim of avoiding strong assumptions. This approach also has the serious side
effect of introducing non-parametric smoothing boundary effects on both sides of the break. These
boundary effects severely compromise inference in the most interesting region of the infection profile,
while simultaneously increasing the importance of the structural assumption at the expense of the data.
Indeed when such a model is built it estimates a large drop even from data simulated from a smooth
infection profile. It also estimates such a drop if the drop’s location is moved (for simulated or real data).
A better approach is to use a smooth time-dilation to relax, but not eliminate, the model smoothness
assumptions in the vicinity of lockdown. The dilation is made sufficient that the model can accurately
capture the extreme scenario in the simulation, but without imposing a break and boundary effects. In
particular fc and its smoothing penalty are computed with respect to a version of time which makes the
day before, of and after lockdown count as 3.5, 6 and 3.5 days, respectively. Obviously regular un-dilated
time is used for mapping infections to deaths. For the extreme simulation, the model then correctly gives
most posterior probability to the day before lockdown as the peak. In contrast the same model for the
real data has very low probability of the peak being the day before lockdown rather than earlier.
Figure 6 shows the results from fitting the time dilated model to the extreme simulation scenario and
to the NHS England hospital data. Even this model, deliberately modified to favour a very abrupt change
at lockdown, suggests that infections started to decline before lockdown, with the most likely day for
the peak only 1 day later than with the un-dilated model. The Supporting Information includes similar
checks for the Flaxman et al. (2020) model, with similar conclusions.
Finally, interpretation of the fatal incidence trajectories as proportional to the overall incidence tra-
jectories rests on an assumption that the infection fatality rate is constant over time. There is evidence
that the hospitalized case fatality rate declined in the two months or so after the peak of the first wave
of infections (Dennis et al., 2021), with this effect not explicable by any detectable change in patient
characteristics. However, on the ground changes in the severity threshold for admission would be very
difficult to detect, seem likely at times when some hospital’s were at or near capacity, and could also
contribute to such a pattern. The Supporting Information includes a check of the impact that the re-
ported improvements would have on the shape of inferred overall incidence. The peak incidence could
be shifted by as much as a day later, and there would be a somewhat slower decline in incidence relative
to the results plotted in Figure 2.
7 Discussion
The analysis in this paper does not absolutely prove that fatal infections in the UK preceded the first
full lockdown by several days, but it very strongly suggests that this is what happened, and the ISARIC
fatal disease duration distribution data, not available in the peer reviewed version of the paper, only
15

































Figure 7: Left, REACT-2 onset of new symptoms per day digitized from Ward et al. (2021), lagged by
the mean 5.8 days from infection to first symptoms. Day 1 is Jan 1 2020. Red lines are the lockdowns.
Rather than simple lagging, this paper’s method could be applied to the onset dates to infer infection
dates given the published infection to onset distribution, but because none of the onset peaks are after
lockdown this can not change the qualitative conclusion (although it would sharpen the peaks a little).
Right ONS published estimated incidence and 95% confidence limits. Red lines are at lockdowns 2 and
3 (the survey was not running at lockdown 1).
strengthens this point further. Since the peer reviewed publication, information has also become available
from the UK’s two main Covid surveys based on proper randomized statistical sampling. The Office for
National Statistics PCR prevalence survey has now published its estimates of incidence. For the second
and third lockdown these support the analysis in this paper. See Figure 7. Furthermore the REACT-2
survey (Ward et al., 2021) has reconstructed numbers of newly symptomatic cases per day from survey
participants testing positive for Covid-19 antibodies. Lagging these by the published mean time from
infection to first symptoms gives the left plot of figure 7. This agrees with the results of this paper for all
three lockdowns. Some differences in relative peak sizes between the series are to be expected if there are
changes in infection fatality rate, and as a result of the vaccination program. Taken together these results,
from the 3 highest quality data sources available for the UK epidemic, leave little room for reasonable
doubt that incidence was in decline before each lockdown. Apparent demonstrations of the contrary
result appear to rely on building it into the modelling assumptions, or on highly informal reasoning
about timings or correlations, or on a view that scientific opinion, in sufficient quantity, outweighs data
and measurement.
The timing result in turn suggests that the measures, and possibly the spontaneous reactions to rising
deaths and cases, preceding lockdowns were probably sufficient to bring the epidemic under control, and
that community infections, unlike deaths, were probably at a low level well before the first lockdown was
eased. Such a scenario would be consistent with the infection profile in Sweden, which began its decline
in fatal infections shortly after the UK, but did so on the basis of measures well short of full lockdown.
The analysis does not in itself say what would have happened without full lockdowns, and must
obviously be weighed against other evidence. No currently available analysis will conclusively deter-
mine what would have happened without full lockdowns, and the state of the art in causal inference is
obviously a very long way from being able to answer this question. Models based on approximations to
the mechanisms of epidemic transmission do not allow reliable answers to these causal questions either.
This is particularly so given the paucity of data with which to validate their component assumptions - a
paucity that only grows more acute as more detail is included in the models. These are not weather or
climate models, based on the bulk properties of enormous numbers of physically well understood inter-
actions of simple molecules, tested and refined against huge quantities of carefully measured calibration
data collected worldwide over decades. Rather they are best working approximations constructed by
experts given the limited information that could be rapidly assembled in a matter of months, and subject
to all the uncertainty this implies. A model does not become a valid basis for casual inference merely by
being described as mechanistic. As the above reanalysis using the Flaxman model serves to emphasise:
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the inclusion of model structure aiming to represent mechanism is no guarantee of improved statistical
inference, and certainly not a justification for treating inference with mechanism based models as causal.
Since this work was first undertaken other low assumption analyses have appeared, in particular
looking for the coincidence of NPI introductions and changepoints in incidence, for example in Germany
and Spain. The results of this paper are in some alignment with such analyses for Germany (Wieland,
2020; Küchenhoff et al., 2020), which also suggest that a decline in incidence preceded the first full
lockdown. Both are based on case data, which are problematic even in Germany which had mass (but
not randomized) testing in place from the start of the epidemic. However it seems likely that the biases in
case data would lead to the start of decline in incidence being estimated as later than it really was, rather
than earlier, so the qualitative conclusion is likely to be robust. In Spain, Santamarı́a and Hortal (2020)
also identify substantial changes in rate of change of incidence before Spanish lockdown based on death
series, but not sufficient to suggest a decline in incidence before lockdown. Based on pre-print versions
of the current paper a number of researchers have also attempted to employ the basic idea of dynamic
model free inference about incidence profiles, but via a simplified method. This method tries to impute
date of infection by subtracting a random draw from the fatal duration distribution from each deceased
patient’s death date. This process is replicated to obtain an expected incidence profile. The method is
invalid, as duration of disease is not independent of time of death, and it will tend to incorrectly show
much less steep, or no, decline before lockdown. See the Supporting Information for a full discussion.
The results of applying the method to data up to mid February 2021, as well as being consistent
with the independent measurements in Figure 7, also provide a picture consistent with the results for
the first lockdown. In particular the results preceding the first lockdown appear consistent with how the
epidemic progressed under later restrictions short of lockdown. This is not the case for the published
analyses suggesting high R and surging incidence on the eve of the first lockdown. The fact that school
re-opening does not appear to be followed by an increase in R is interesting: whether it relates to people
deciding to keep school children apart from the vulnerable, which is anecdotally plausible, or to other
factors, is unclear. While tempting, it is difficult to interpret the later patterns in terms of the new,
apparently more infectious, variant that emerged in late 2020: there is confounding with seasonality
of transmission, behavioural changes around the end of year holidays and with the roll out of effective
vaccines from late December onwards. Greater clarity on these issues may emerge in future, particularly
if the UK ONS Covid surveillance data eventually becomes public in raw form.
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Supporting Information for ‘Inferring UK COVID-19 fatal infection
trajectories from daily mortality data’
1 Feasible direct inference of incidence from randomized PCR testing
Useful estimates of incidence can be obtained from properly randomized PCR surveillance testing, even
using numbers of tests well within the laboratory capacity available early in the epidemic. This section
provides a simple illustration of this, by sketching a method and showing its ability to capture incidence
profiles at the sort of levels that are important for decision making - i.e. at a level slightly over 1 per
1000 per day. For illustrative purposes I consider a very simple model of PCR positivity in which the
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proportion, P , of people potentially testing positive is governed by the simple ODE model (ẋ denoting
the time derivative of x)
Ṗ = f(t)− δP
where f is the incidence (strictly speaking of potential PCR positivity) as a proportion of the population,
and 1/δ is the mean duration of positivity. One could of course substitute any number of alternative
models for the assumption of an exponential distribution of the time that subjects are PCR positive, with-
out changing the basic approach discussed here. With only slightly more effort a stochastic formulation
could also be substituted (although is likely to add little, given the large numbers involved). The number
testing positive in random samples of size N from the population is then given by
yi ∼ binom(N,αP )
where α is the test sensitivity (which is measurable in a reasonably direct manner). As in the main paper,
we can represent f semi-parametrically, e.g. using a smoothing spline, so that
f(t) = exp(Xtβ)
where Xt is a row vector of spline basis functions evaluated at time t. Writing the derivative of P w.r.t.
βj as Pβj we have an ODE
Ṗβj = f(t)Xtj − δPβj
for each such derivative (known as sensitivities in this context). Given any value of β it is straightfor-
ward to solve for P and the sensitivities, for example by 4th order Runge-Kutta integration. Hence the
log likelihood and its derivative are readily evaluated, and the empirical Bayes approach given in the
main paper can be used to find the posterior models, β̂, an appropriate smoothing parameter and the
large sample posterior covariance matrix. To avoid requiring the second derivative ODE system, β̂ can
be obtained by quasi-Newton optimization, with the Hessian required for smoothing parameter update
obtained from the first derivative of the log likelihood by finite differencing.
By way of illustration, data were simulated from such a model for 100 days, with 400 tests per day
(2800 per week) conducted on randomly selected people from a general population subject to the true
incidence curve shown in red in figure 8, and δ = 0.1. The method was then used to reconstruct the
incidence curve (here 100% sensitivity was assumed, since sensitivity is a simple scale parameter in this
problem). Three random replicate reconstructions are shown in figure 8. Uncertainty is wide at the end of
the data, but usable for 10 days earlier. Of course the swab to testing lag adds to this. Larger sample sizes


































































Figure 8: Three replicates of incidence rates reconstructed from simulated PCR testing data. True inci-
dence is in red. Reconstructions and 2 standard error bands in black. Grey circles show the number of
positive tests each day, divided by 4000. Obviously positivity lags incidence.
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Figure 9: Illustration of the failure of a simple imputation method to correctly reconstruct an incidence
curve consistent with the observed deaths. Symbols are observed English hospital deaths. Grey curves
are infections imputed by the incorrect method given in the text. The black curve is the mean imputed
incidence. The blue curve is the expected daily death trajectory implied by the black curve. If the method
were correct it should pass through the data points. The red vertical line marks the first day of the first
UK lockdown.
would be needed if local/regional estimates are required, but for the ‘whole country’ picture considered
in the main paper such direct estimation is clearly feasible.
2 How not to infer fatal incidence
Several researchers picked up the pre-print version of this paper (Wood, 2020) and have attempted to use
the basic idea of inferring fatal incidence directly from death trajectories and the fatal disease distribution,
but via a simple ‘imputation’ method. Suppose the ith patient died on day ti. A random draw from the
fatal disease duration distribution, τi, is subtracted from their death day to give an imputed infection day,
ti−τi. Repeating this for all deaths generates an imputed fatal incidence curve. Repeating the imputation
many times allows an expected incidence curve to be generated.
This method is not valid. It is completely plausible that duration of disease is independent of time of
infection, but not of time of death. Further, unless incidence and deaths are at some constant equilibrium,
duration of disease can not be independent of both time of infection and time of death: when deaths are
rising, we inevitably see the deaths from short duration diseases before those from longer durations.
Since the imputation method assumes independence of ti and τi it can not be valid. Figure 9 shows that
this is not a minor concern. It shows incidences reconstructed using the described imputation method. I
then added random draws from the fatal duration distribution to the imputed days of infection, to obtain
the expected daily deaths implied by the imputed incidence trajectory (essentially the ‘sanity check’
applied in the main paper). The expected daily deaths are an exceedingly poor fit to the data.
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3 Fatal disease duration distribution
Fatal disease duration data for England are available in the CHESS1 database, access to which is re-
stricted to particular research groups under strict conditions. With the kind help of Robert Verity from
Imperial College I was able to access information on the distribution of fatal disease durations for 3274
deaths that occurred before 10 June 2020 with recorded symptom onset before 1 May. The information
provided was a bar chart of the duration distribution by day, on condition that only the information about
the model fitted to the data be distributed further. The data were not filtered to remove hospital acquired
infections, but it was not possible to obtain data only for those with onset before hospitalization. This is
problematic for two reasons. Firstly, for inferring the time course of community acquired fatal infections
it is the distribution of fatal disease durations for community acquired infections that is required, which
the raw data do not provide: for example, they contain substantial proportions of durations of 1-3 days
that appear clinically implausible for deaths from community acquired COVID-19 (see, e.g. Huang et al.,
2020; Wang et al., 2020; Zhou et al., 2020; Tay et al., 2020). Secondly the raw data are from a relatively
small proportion of the total deaths. It is very unlikely that the ratio of hospital to community acquired
infections in this sample is representative: for hospital acquired infections the onset of symptoms is
presumably almost always known, and hence more likely to be recorded than for community acquired
infections. This makes the raw distribution unrepresentative of the distribution for all deaths and also not
usefully informative about the proportion of all deaths that are from hospital acquired infection. Note
also that without more extensive data access it is not possible to rule out that some proportion of what
appear to be hospital acquired infections really represent data problems (for example recording onset day
as hospital admission day).
To deal with these issues a two component mixture model was fitted to data digitized from the bar
chart, consisting of a gamma distribution (representing hospital acquired infections) and a log-normal
distribution (representing community acquired infections). Parameterization was such that the log-
normal had the longer mean duration. The higher the gamma mixture proportion the larger the log-
normal mean. To find the shortest mean community acquired duration defensible from the data, the
gamma mixture proportion was reduced to the point at which the log likelihood was about 4 below the
MLE (decreasing further decreases the log-likelihood sharply, pushes a χ2 goodness of fit statistic into
the significant range, and starts to suggest rather high probabilities of very short disease durations for the
log-normal mixture component). This point has about 0.7 of the mixture contributed by the community
infection component. The resulting log-normal community infection fit has a mean of 21 days and a
standard deviation of 12.7. Longer durations would be slightly more consistent with the data under the
mixture model, but given the aims of this paper it is better to use conservatively short estimates here.
Figure 10 shows the various estimated distributions over the duration range observed in the CHESS data.
The log-normal model has an earlier mode, but longer tail, than the Verity et al. (2020) model used in
earlier versions of this paper.
It should perhaps be noted that this model was obtained before I was aware of Linton et al. (2020)
and Wu et al. (2020). Note also that the data for this model were obtained before the decision to attribute
deaths to Covid-19 only if there was a positive test within the 28 days preceding death: this may be the
reason for the model’s slightly heavier tail. Otherwise the results are broadly in agreement with those
from the published studies.
Assuming independence of incubation period and onset to death period, the preceding fit and the
McAloon et al. (2020) incubation period imply that the infection-to-death distribution for the community
acquired infection component can be well modelled by a log-normal distribution with log scale mean and
standard deviation of 3.19 and 0.44, respectively. That is a mean of 26.8 days and standard deviation of
12.4 days. The community infection distribution component is shown in blue in figure 2 of the paper.
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Figure 10: Onset to death duration distribution models. The red curve is the log-normal mixture com-
ponent for community acquired infection fitted to the CHESS data, the dashed grey curve is the gamma
mixture component representing hospital acquired infection and the continuous grey curve the com-
bined model. The combined model is not directly usable: see text. The black curves are: continuous
Verity et al. (2020); dashed Linton et al. (2020); dotted Wu et al. (2020). The mixture model was esti-
mated by maximum likelihood, with the hospital acquired mixture proportion reduced until the profiled
log likelihood was reduced to 4 below the MLE, to obtain the shortest mean community acquired dura-
tion consistent with the data under this model. The black curves in no way inform the red curve in the
fitting.
More recently results of Robert Verity’s own more detailed analysis of the CHESS data have appeared
in Knock et al. (2020). The full fitted distribution is not given, but the figures that are reported imply a
slightly shorter mean duration of just over 24 days. This is just under a day and a half less than for
the mean duration for the average distribution used in the main paper, and within the uncertainty range
considered in the paper.
A second less problematic source of information is the ISARIC study, which I was unaware of before
the peer reviewed version of this paper was published. Pritchard et al. (2020) summarizes information
on the patients enrolled in this study up until October 2020. At this time point the recruitment rate to the
study was quite low, so that right truncation problems should have a fairly low impact. Figure 12 of the
study plots the observed cumulative distribution function for time from hospitalization to death for the
24421 study patients who had died up to the time of the report. This can be digitized and converted to a
probability function, which can be well approximated by a log-normal density (mean 12.47 and standard
deviation 10.97) - see Figure 11. Pritchard et al. (2020) report that the time from onset of symptoms
to hospitalization had a mean of 7.7 days and standard deviation of 6.1. So the mean time from onset
to death is about 20.2 days. Assuming independence of the two durations the standard deviation of the
onset to death duration is then 12.55.
Modelling the onset to hospital duration as log normal, the best fit lognormal approximation to the
distribution of time from infection to death then has a mean of 27.7 and standard deviation 12.0 (an
alternative gamma approximation was a poor fit). Note that this distribution estimate does not take into
account the small amount of right truncation present in the data, so might be slightly biased towards
lower durations.
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Figure 11: Empirical probability function of hospitalization to death interval distribution obtained by dif-
ferencing the CDF digitized from Figure 12 of Pritchard et al. (2020), fitted (to minimize KL-divergence)
by a log normal density.
4 Possible age structure effects
One possible concern is that if the distribution of fatal disease duration is strongly age dependent and
the age distribution shifts over time, then the results of the paper’s analysis could be biased in ways
that could be difficult to correct. In fact Dennis et al. (2021) looked for temporal changes in patient
characteristics including age as possible explanations for the mortality improvements that they report
in the early months of the epidemic, but did not find age distribution changes in hospitalized patients.
Additionally Knock et al. (2020) analysed English hospital data to parameterize a detailed age structured
epidemic and hospital model, but while they report age effects on rates of hospitalization and transfer to
ICU, with different distributions of time to death for ICU and general ward patients, those distributions
are not reported to be age dependent.
While both the cited analyses rely on confidential data with stringently controlled access, it is possible
to look for evidence of age distribution shifts in the weekly England and Wales Covid-19 deaths by age
data publicly available from the UK Office for National Statistics2. These data give total England and
Wales Covid-19 deaths each week in 20 age bands, < 1, 1-4, 5-9 , . . . , 85-89 and 90+. They also record
the total number of Covid-19 deaths each week in care homes for the elderly in England and Wales. To
look for age distribution changes in hospitalized patients, it is necessary to remove the care home deaths
from the weekly totals. The care home deaths are not broken down by age, so I simply reduced the total
deaths in the last three age classes by the same proportion, in order to reduce the each weekly total deaths
by the correct amount.
A negative binomial generalized additive model was then fitted to the data, with the structure
log{E(deathi)} = α+ f1(ai) + f2(wi) + f3(ai, wi)
where ai denotes the age class (a number from 1 to 20) and wi is the week. f1 and f2 are univariate
splines, while f3 is a tensor product interaction spline, (without the main effects). Thus f3 represents
any change in age distribution of deaths over time. See Wood (2017) section 5.6.3 for details. f3 is
statistically significant, but the effect size is too small to be biologically significant. Figure 12 shows
the estimated model components. Leaving the care home deaths in the totals leads to a slightly stronger
























































Figure 12: Generalized additive model term estimates on the log link scale, from fitting to England and
Wales hospital death by age data. Left is the effect of week, middle of age group and right of their
interaction. The interaction ranges over approximately -0.2 to 0.2, and is clearly a very small effect
relative to the others.
namics of the care home epidemic relative to the community epidemic, as discussed in the main paper.
The main effects are essentially unchanged from those shown.
5 Further model checking of relaxed Flaxman model
The time dilation check from the Model checking section of the paper was also applied to the relaxed
Flaxman et al. (2020) model, with the results shown in the upper panel of figure 13. Again the results
are qualitatively similar to the undilated case, despite modifying the model to favour sharp change in R
at lockdown. Although highly problematic for the reasons discussed in the paper, the results of a check
using a model in which a step change was forced to occur at lockdown is also shown in the lower row
of figure 13. The boundary condition artefacts that this introduces are clearly visible, but in any case the
inferred R on the eve of lockdown is about 1.5. This is substantially below the Flaxman et al. estimates
of close to 3.
6 Sensitivity to mortality rate reductions
There is evidence for reductions in the hospital mortality rates in England from the week of 29th March
2020 until the end of June, with this reduction apparently not being attributable to any change in patient
characteristics: Dennis et al. (2021) report mortality rates reducing by a multiplicative factor of about
.985 per day (before then, if anything the death rates were increasing). While this does not undermine
inference of fatal infection incidence, it obviously means that fatal disease incidence should probably not
be interpreted as proportional to overall incidence. Given the uncertainties in the Dennis et al. (2021)
results, a direct correction is difficult. Furthermore ruling out changes in severity of disease required
for admission over the first wave is also not possible: for example, general practitioners (family doc-
tors) were initially working with central guidance on when patients should self isolate, but not when
they should be sent to hospital, so it seems unlikely that on the ground admission criteria were constant,
especially at times when some hospitals were at or near capacity. However a sensitivity test is straight-
forward. The observed deaths each day can simply be scaled up by the ratio of the number of deaths
expected without improvements to the number expected with improvements (assuming .985 per day im-
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Figure 13: Model checking plots for the Flaxman et al. (2020) model. The upper row shows the results
of applying a time dilation around lockdown to ensure that any very rapid change in R at that point can
be accommodated by the model. The results are similar to the undilated case. The lower row shows a
model which forces a step change at lockdown- notice the severe boundary uncertainty in the vicinity of
lockdown introduced by this (see text for discussion). Even with this model R is about 1.5, substantially
below the Flaxman et al. (2020) estimates of around 3 on the eve of lockdown.
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Figure 14: Sensitivity of the results to improvements in the IFR. To interpret the fatal incidence trajec-
tories as proportional to overall disease incidence, the IFR has to be constant. There is evidence for this
not being the case as hospital care has improved. These plots show inferred incidence from death data
‘corrected’ for the mortality rate improvements estimated in Dennis et al. (2021). Note the very slight
rightward shift in the peak timing distribution, and somewhat slower decay in the incidence profile.
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provement from 29th March). This has the effect of making the downward tail of the adjusted deaths
series decay more slowly than for the observed deaths (see right panel of fig 14). Applying the method to
the English hospital data then gives the results in figure 14. There is a shift in the inferred peak incidence
to later, and the incidence decays more slowly, relative to the results shown in the main paper. Note that
the mortality improvements only apply to hospital deaths, not care home deaths.
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